Sentinel lymph node biopsy for breast cancer

Richard J Bold; M. Schlieman; B. N. Fahy

Sentinel lymph node biopsy for breast cancer

Richard J Bold, M. Schlieman, B. N. Fahy

Surgical Oncology

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Sentinel lymph node biopsy (SLNB) is an emerging surgical technique to improve lymph node staging for breast cancer. Despite the rapid development of this technique, there remain aspects of SLNB that need to be further defined to provide a standardized approach. Variables, including patient selection, technical details for the performance of SLNB, extent of pathologic evaluation of the sentinel lymph node, and the impact of micrometastases, are areas of controversy. This paper reviews the controversies and discusses available data as well as personal experience and opinion.

Original language	English (US)
Pages (from-to)	347-357
Number of pages	11
Journal	Cancer Biotherapy and Radiopharmaceuticals
Volume	16
Issue number	5
State	Published - 2001

ASJC Scopus subject areas

Cancer Research
Pharmacology
Oncology

Fingerprint Dive into the research topics of 'Sentinel lymph node biopsy for breast cancer'. Together they form a unique fingerprint.

Cite this

@article{590455633ca5495eb451a5c5d98ffdc2,

title = "Sentinel lymph node biopsy for breast cancer",

abstract = "Sentinel lymph node biopsy (SLNB) is an emerging surgical technique to improve lymph node staging for breast cancer. Despite the rapid development of this technique, there remain aspects of SLNB that need to be further defined to provide a standardized approach. Variables, including patient selection, technical details for the performance of SLNB, extent of pathologic evaluation of the sentinel lymph node, and the impact of micrometastases, are areas of controversy. This paper reviews the controversies and discusses available data as well as personal experience and opinion.",

author = "Bold, {Richard J} and M. Schlieman and Fahy, {B. N.}",

year = "2001",

language = "English (US)",

volume = "16",

pages = "347--357",

journal = "Cancer Biotherapy and Radiopharmaceuticals",

issn = "1084-9785",

publisher = "Mary Ann Liebert Inc.",

number = "5",

}

TY - JOUR

T1 - Sentinel lymph node biopsy for breast cancer

AU - Bold, Richard J

AU - Schlieman, M.

AU - Fahy, B. N.

PY - 2001

Y1 - 2001

N2 - Sentinel lymph node biopsy (SLNB) is an emerging surgical technique to improve lymph node staging for breast cancer. Despite the rapid development of this technique, there remain aspects of SLNB that need to be further defined to provide a standardized approach. Variables, including patient selection, technical details for the performance of SLNB, extent of pathologic evaluation of the sentinel lymph node, and the impact of micrometastases, are areas of controversy. This paper reviews the controversies and discusses available data as well as personal experience and opinion.

AB - Sentinel lymph node biopsy (SLNB) is an emerging surgical technique to improve lymph node staging for breast cancer. Despite the rapid development of this technique, there remain aspects of SLNB that need to be further defined to provide a standardized approach. Variables, including patient selection, technical details for the performance of SLNB, extent of pathologic evaluation of the sentinel lymph node, and the impact of micrometastases, are areas of controversy. This paper reviews the controversies and discusses available data as well as personal experience and opinion.

UR - http://www.scopus.com/inward/record.url?scp=0035217908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035217908&partnerID=8YFLogxK

M3 - Article

C2 - 11776752

AN - SCOPUS:0035217908

VL - 16

SP - 347

EP - 357

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

SN - 1084-9785

IS - 5

ER -